Institutional Capital Overview
Executive Summary
Evident is building litigation risk mitigation infrastructure for regulated institutions.
The platform enforces tamper-resistant, time-sequenced validation across critical record lifecycle events, strengthening defensibility in environments where regulatory exposure and audit scrutiny are material.
The Institutional Risk Problem
Healthcare and judicial systems face increasing litigation exposure, regulatory enforcement, and compliance pressure.
Existing systems manage data but do not guarantee defensible sequence integrity across record lifecycle events. Ambiguity in sequencing creates measurable legal and operational risk.
Healthcare litigation exposure exceeds $55B annually in the United States.
Solution Architecture
Evident integrates as compliance-grade infrastructure middleware within existing institutional systems.
The platform enforces immutable event sequencing, structured audit persistence, and defensible chain-of-custody validation without requiring replacement of primary systems of record.
Initial Deployment Focus
- Healthcare mortality workflow validation
- Institutional audit chain persistence
- Judicial record sequencing validation
Revenue Model
Enterprise SaaS infrastructure model targeting annual contract values between $75K–$250K per institutional deployment.
Expansion strategy includes multi-site health systems, cross-jurisdictional integrations, and broader regulated enterprise adoption.
Buyer Profile
Primary buyers include CIOs, Chief Compliance Officers, Chief Risk Officers, and General Counsel within healthcare systems and judicial institutions.
Capital Raise
Target raise: $1–2M institutional pre-seed via SAFE.
- Core architecture hardening
- Regulated pilot integrations
- Security and compliance validation
- Enterprise deployment readiness
Litigation Risk Infrastructure delivered as compliance middleware, with long-term objective to become the sequencing standard across regulated markets.
Full Diligence Materials
Detailed architecture documentation, roadmap, and financial model available to approved investors.
Request Dataroom Access